阿里健康斥資約81億港元收購ALI JK ZNS
格隆匯2月7日丨阿里健康(00241.HK)公佈,於2月6日,公司與Ali JK Nutritional Products Holding Limited(阿里巴巴控股的直接全資附屬公司)訂立購股協議。據此,公司將收購Ali JK ZNS Limited(為阿里巴巴控股為持有目標業務而根據英屬維爾京羣島法律註冊成立間接全資離岸控股公司)全部股權。總對價為80.75億港元,並將透過公司在交割時向賣方發行約8.6億股對價股份支付對價。據悉,對價股份發行價較收市價每股11.62港元折讓19.3%。截至2019年3月31日止財政年度,目標業務產生總商品交易額約人民幣95.75億元,並擁有約3,580萬名年度活躍買家。於2020年1月31日,目標業務擁有逾530名目標商家獲天貓主體及淘寶中國授權在天貓平台銷售目標產品及服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.